TP5 triggers signal transduction involving mitogen activated protein kinases in monocytes

Journal of Receptor and Signal Transduction Research

Volumn 19, Issue 1-4, 1999, Pages 155-166

  Gonser, S ^a   Crompton, N E A ^b   Weber, P J A ^a   Beck Sickinger, A G ^a   Folkers, G ^a  

^a ETH ZURICH   (Switzerland)

^b PAUL SCHERRER INSTITUTE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; THYMOPENTIN; THYMOPOIETIN;

AMINO TERMINAL SEQUENCE; CELL MATURATION; CONFERENCE PAPER; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; THYMUS;

BOVINAE;

EID: 0033035122     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899909036642     Document Type: Conference Paper

References (25)

1. Goldstein, G. Isolation of bovine thymin: A polypeptide hormone of the thymus. Nature 247, 11-14, 1974.
2. Basch, R. S.; and Goldstein, G. Induction of T-cell differentiation in vitro by thymin, a purified polypeptide hormone of the thymus. Proc. Natl. Acad. Sci. USA 71, 1474-1478, 1974.
3. Sunshine, G. H.; Basch, R. S.; Coffey, R. G.; Cohen, K. W.; Goldstein, G.; and Hadden, J. W. Thymopoietin enhances the allogeneic response and cyclic GMP levels of mouse peripheral, thymus-derived lymphocytes. J. Immunol. 120, 1594-1599, 1978.
4. Harris, C. A.; Andryuk, P. J.; Cline, S.; Chan, H. K.; Natarajan, A.; Siekierka, J. J.; and Goldstein, G. Three distinct thymopoietins are derived from alternatively spliced mRNAs. Proc. Natl. Acad. Sci. USA 91, 6283-6287, 1994.
5. Harris, C. A.; Andryuk, P. J.; Cline, S.; Mathew, S.; Siekierka, J. J.; and Goldstein, G. Structure and mapping of the human thymopoietin (TMPO) gene and relationship of human TMPO β to the rat lamin-associated polypeptide 2. Genomics 28, 198-205, 1995.
6. Furukawa, K.; Pante, N.; Aebi, U.; and Gerace, K., Cloning of a cDNA for lamina associated polypeptide 2 (LAP2) and identification of regions that specify targeting to the nuclear envelope. EMBO J. 14, 1626-1636, 1995.
7. Theodor, L.; Shoham, J.; Berger, R.; Gokkel, E.; Trachtenbrot, L.; Simon, A. J.; Nir, U.; Ilan, E.; Zevin-Sonkin, D.; Friedman, E.; and Rechavi, G. Ubiquitous expression of a cloned murine thymopoietin cDNA. Acta Haematologica 97, 153-163, 1997.
8. Goldstein, G.; Scheid, M. P.; Boyse, E. A.; Schlesinger, D. H.; and Van Wauwe, J. A synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopoietin. Science 204, 1309-1310, 1979.
9. Malicevic, Z.; Kojic, L. Z.; and Stamenovic, B. A. Neuromodulation of synaptic transmission with thymopentin. Vojnosanitetski Pregled 51, 192-200, 1994.
10. Caruso, C.; Candore, G.; Modica, M. A.; Di Giulio, C.; Ingrassia, A.; and Di Lorenzo, G. In vitro thymopentin modulation of mitogen responsive T-cell precursor frequency. Thymus 14, 249-251, 1991.
11. Audhya, T.; Heaver, G. A.; Kroon, D. J.; and Goldstein, G. Cooperativity of thymopoietin 32-36 (the active site) and thymopoietin 38-45 in receptor binding. Regul. Pept. 9, 155-164, 1984.
12. Sundal, E. Thymopentin in Cancer. Curr. Ther. Res. 51, 906-924, 1992.
13. Hu, C.; Radelli, L.; Scorza, R.; Bonara, P.; Perego, R.; and Fantuzzi, G. In vivo enhancement of NK-cell activity by thymopentin. Int. J. Immunopharmac. 12, 193-197, 1990.
14. Covelli, V.; Munno, I.; Altamura, A.; Pellegrino, N.M.; Decandia, P.; and Jirillo, E. Administration of thymopentin to patients with phobic disorders improves depressed phagocytotic functions. Immunopharm. & Immunotox. 12, 619-631, 1990.
15. Sundal, E. Thymopentin and infection prophylaxis in cancer patients: A review. Int. J. Immunotherapy 8, 101-113, 1992.
16. Conant, M. A.; Calabrese, L. H.; Thompson, S. E.; Poiesz, B. J.; Rasheed, S.; Hirsch, R. L.; Meyerson, L. A.; Kremer, A. B.; Wang, C. C.; and Goldstein, G. Maintenance of CD4+ cells by thymopentin in asymptomatic HIV-infected subjects: results of a double-blind, placebo-controlled study. AIDS 6, 1335-1339, 1992.
17. Lazzarin, A.; Barcellini, W.; Foppa, C. U.; Borghi, M. O.; Franzetti, F.; Cinque, P.; and Moroni, M. Experiences with immunomodulant agents in HIV infections. Acta Haematologica 78, 84-90, 1987.
18. Weber, P. J. A.; and Beck-Sickinger, A. G. Comparison of the photochemical behavior of four different photoactivatable probes. J. Pept. Res. 49, 375-383, 1997.
19. Weber, P. J. A.; Bader, J. E.; Folkers, G.; and Beck-Sickinger, A. G. A fast and inexpensive method for N-terminal fluorescein-labeling of peptides. Bioorg. Med. Chem. Lett. 8, 597-600, 1998.
20. Towbin, H.; Staehelin, T., and Gordon, I. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350-4354, 1979
21. Sambrook, J.; Fritsch, E. F.; and Maniatis, T. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory Press, Second Edition, 1989
22. Hill, C. S.; Treisman, R. Transcriptional regulation by extracellular signals: mechanisms and specifity. Cell 80, 199-211, 1995.
23. Traverse, S.; Gomez, N.; Paterson, H.; Marshall, C.; and Cohen, P. Sustained activation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem. J. 288, 351-355, 1992.
24. Banchereau, J.; and Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252, 1998.
25. Horton, M. A. Blood cell biochemistry, Volume 5, Macrophages and related cells. Plenum Press New York, 1993.